Memory Binding Test immediate free recall

Biomarker

1 paper studies it1 finding

  • Humans1

Upstream

1

Preclinical Alzheimer's disease

downin humans1

1 study
  1. Preclinical Alzheimer's disease decreases Memory Binding Test immediate free recall in humans.

    “The preclinical groups performed worse on MBT immediate free recall at baseline than the healthy group”

    Humanspreclinical diseasen = 149

    The memory binding test in a longitudinal study of cognitive aging and preclinical disease

    Neuropsychology

More on Preclinical Alzheimer's disease

Latest